FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2057156798> ?p ?o ?g. }

• W2057156798 endingPage "353" @default.
• W2057156798 startingPage "350" @default.
• W2057156798 abstract "Raloxifene, a selective estrogen receptor modulator, has beneficial estrogen agonist effects on bone and cardiovascular risk factors and estrogen antagonist effects on the breast and uterus. Limited clinical data have shown a sustained decrease in total cholesterol, low-density lipoprotein cholesterol, and homocysteine levels; an elevated homocysteine level is an independent risk factor for atherosclerosis. All of these studies were conducted in relatively young populations of women (mean age, 52-54 years). Raloxifene does not affect hot flushes, a major immediate symptom of menopause. This drug may therefore be useful in older women to prevent osteoporosis and cardiovascular disease. The aim of this clinical study was to evaluate the effects of raloxifene on plasma lipids and homocysteine in older women.The subjects were 45 healthy postmenopausal women, aged 60 to 70 years. The women were randomly assigned to therapy with raloxifene or placebo, 60 mg/d for 1 year. Twenty-six women received raloxifene and 19 received placebo. Checkups were performed every 3 months. At baseline and after 3, 6, 9, and 12 months of treatment we measured homocysteine, total serum cholesterol, triglycerides, and both high-density lipoprotein and low-density lipoprotein cholesterol.An effect on lipids was evident by 3 months with no significant additional modification at 12 months. Mean low-density lipoprotein cholesterol levels were lowered by 15% and total cholesterol was lowered by 8.5%. No reduction in high-density lipoprotein cholesterol or triglycerides was observed. After 3 months of therapy, homocysteine was significantly lower than at baseline (9.9 +/- 1.6 vs 11 +/- 2.1 micromol/L; P < .05). The greatest reduction with respect to baseline was reached after 6 months of therapy (-19.5% +/- 3%; P < .05).The results of our study show that raloxifene at a dose of 60 mg/d reduces serum concentrations of low-density lipoprotein cholesterol and total cholesterol in healthy older women. Our study shows that in older women raloxifene leads to a 19.5% +/- 3% reduction in fasting homocysteine levels. Raloxifene may have a favorable effect on the incidence of cardiovascular disease in older women." @default.
• W2057156798 created "2016-06-24" @default.
• W2057156798 creator A5009785362 @default.
• W2057156798 creator A5012657070 @default.
• W2057156798 creator A5022437804 @default.
• W2057156798 creator A5036057981 @default.
• W2057156798 creator A5049594185 @default.
• W2057156798 creator A5055455626 @default.
• W2057156798 date "2001-02-01" @default.
• W2057156798 modified "2023-10-17" @default.
• W2057156798 title "Randomized control study of the effects of raloxifene on serum lipids and homocysteine in older women" @default.
• W2057156798 cites W1582396128 @default.
• W2057156798 cites W1853715951 @default.
• W2057156798 cites W1970028985 @default.
• W2057156798 cites W1982556373 @default.
• W2057156798 cites W1995781460 @default.
• W2057156798 cites W1997883187 @default.
• W2057156798 cites W2005375443 @default.
• W2057156798 cites W2020967365 @default.
• W2057156798 cites W2031469248 @default.
• W2057156798 cites W2047298742 @default.
• W2057156798 cites W2053593143 @default.
• W2057156798 cites W2055900440 @default.
• W2057156798 cites W2059457537 @default.
• W2057156798 cites W2062620516 @default.
• W2057156798 cites W2075980325 @default.
• W2057156798 cites W2080895280 @default.
• W2057156798 cites W2110807383 @default.
• W2057156798 cites W2113264115 @default.
• W2057156798 cites W2121509117 @default.
• W2057156798 cites W2123507435 @default.
• W2057156798 cites W2125756592 @default.
• W2057156798 cites W2163248521 @default.
• W2057156798 cites W2323923429 @default.
• W2057156798 cites W2333702587 @default.
• W2057156798 doi "https://doi.org/10.1067/mob.2001.111065" @default.
• W2057156798 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11228485" @default.
• W2057156798 hasPublicationYear "2001" @default.
• W2057156798 type Work @default.
• W2057156798 sameAs 2057156798 @default.
• W2057156798 citedByCount "64" @default.
• W2057156798 countsByYear W20571567982012 @default.
• W2057156798 countsByYear W20571567982013 @default.
• W2057156798 countsByYear W20571567982016 @default.
• W2057156798 countsByYear W20571567982020 @default.
• W2057156798 countsByYear W20571567982022 @default.
• W2057156798 crossrefType "journal-article" @default.
• W2057156798 hasAuthorship W2057156798A5009785362 @default.
• W2057156798 hasAuthorship W2057156798A5012657070 @default.
• W2057156798 hasAuthorship W2057156798A5022437804 @default.
• W2057156798 hasAuthorship W2057156798A5036057981 @default.
• W2057156798 hasAuthorship W2057156798A5049594185 @default.
• W2057156798 hasAuthorship W2057156798A5055455626 @default.
• W2057156798 hasConcept C121608353 @default.
• W2057156798 hasConcept C126322002 @default.
• W2057156798 hasConcept C134018914 @default.
• W2057156798 hasConcept C142724271 @default.
• W2057156798 hasConcept C204787440 @default.
• W2057156798 hasConcept C27081682 @default.
• W2057156798 hasConcept C2776541429 @default.
• W2057156798 hasConcept C2777090595 @default.
• W2057156798 hasConcept C2777164284 @default.
• W2057156798 hasConcept C2777944059 @default.
• W2057156798 hasConcept C2778163477 @default.
• W2057156798 hasConcept C2778562196 @default.
• W2057156798 hasConcept C2779889926 @default.
• W2057156798 hasConcept C2780072125 @default.
• W2057156798 hasConcept C2780092750 @default.
• W2057156798 hasConcept C2780541478 @default.
• W2057156798 hasConcept C530470458 @default.
• W2057156798 hasConcept C71924100 @default.
• W2057156798 hasConcept C84606932 @default.
• W2057156798 hasConceptScore W2057156798C121608353 @default.
• W2057156798 hasConceptScore W2057156798C126322002 @default.
• W2057156798 hasConceptScore W2057156798C134018914 @default.
• W2057156798 hasConceptScore W2057156798C142724271 @default.
• W2057156798 hasConceptScore W2057156798C204787440 @default.
• W2057156798 hasConceptScore W2057156798C27081682 @default.
• W2057156798 hasConceptScore W2057156798C2776541429 @default.
• W2057156798 hasConceptScore W2057156798C2777090595 @default.
• W2057156798 hasConceptScore W2057156798C2777164284 @default.
• W2057156798 hasConceptScore W2057156798C2777944059 @default.
• W2057156798 hasConceptScore W2057156798C2778163477 @default.
• W2057156798 hasConceptScore W2057156798C2778562196 @default.
• W2057156798 hasConceptScore W2057156798C2779889926 @default.
• W2057156798 hasConceptScore W2057156798C2780072125 @default.
• W2057156798 hasConceptScore W2057156798C2780092750 @default.
• W2057156798 hasConceptScore W2057156798C2780541478 @default.
• W2057156798 hasConceptScore W2057156798C530470458 @default.
• W2057156798 hasConceptScore W2057156798C71924100 @default.
• W2057156798 hasConceptScore W2057156798C84606932 @default.
• W2057156798 hasIssue "3" @default.
• W2057156798 hasLocation W20571567981 @default.
• W2057156798 hasLocation W20571567982 @default.
• W2057156798 hasOpenAccess W2057156798 @default.
• W2057156798 hasPrimaryLocation W20571567981 @default.
• W2057156798 hasRelatedWork W1532041217 @default.
• W2057156798 hasRelatedWork W1820167787 @default.

• next